Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SHINGRIX GLAXOSMITHKLINE INC Actual shortage 50MCG Updated Report 2024-04-25 226055
CYMBALTA ELI LILLY CANADA INC Anticipated shortage 30MG Updated Report 2024-04-25 220039
AURO-OLMESARTAN HCTZ AURO PHARMA INC Actual shortage 12.5MG 20MG Updated Report 2024-04-25 106080
STATEX TAB 5MG PALADIN LABS INC. Actual shortage 5MG Updated Report 2024-04-25 224966
AURO-OLMESARTAN HCTZ AURO PHARMA INC Actual shortage 25MG 40MG Updated Report 2024-04-25 108676
SANDOMIGRAN DS PALADIN LABS INC. Actual shortage 1MG Updated Report 2024-04-25 205711
AURO-OLMESARTAN HCTZ AURO PHARMA INC Actual shortage 12.5MG 40MG Updated Report 2024-04-25 108673
XARELTO BAYER INC Anticipated shortage 10MG New Report 2024-04-25 226202
TEVA-TADALAFIL TEVA CANADA LIMITED Resolved 5MG Updated Report 2024-04-25 223859
TEVA-TELMISARTAN TEVA CANADA LIMITED Resolved 80MG Updated Report 2024-04-25 215728

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
DELATESTRYL BAUSCH HEALTH, CANADA INC. To be discontinued 200MG Updated Report 2024-04-25 221772
STRATTERA ELI LILLY CANADA INC Discontinued 18MG Updated Report 2024-04-24 171480
DULOXETINE SANIS HEALTH INC Reversed 30MG Updated Report 2024-04-23 219618
LIDOCAINE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED Discontinued 10MG Updated Report 2024-04-22 225805
MYLAN-VERAPAMIL MYLAN PHARMACEUTICALS ULC Discontinued 80MG Updated Report 2024-04-12 224846